Lamotrigine Tablet
Product Images NDC 62332-039

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 62332-039). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lamotrigine 100 mg

Lamotrigine Tablets USP 100 mg oral tablets, presented in a label for a 30-tablet package by Alembic Pharmaceuticals Inc. The label includes dosing instructions to see the package insert, storage conditions, and manufacturing information for Alembic Pharmaceuticals Limited in India and Alembic Pharmaceuticals, Inc. in the USA. The National Drug Code (NDC) is 62332-038-30.*

FDA Label Image

Lamotrigine 150 mg

Label for Lamotrigine Tablets USP 150 mg, oral tablets manufactured by Alembic Pharmaceuticals Inc. The label includes dosage and storage instructions, states Rx only, and notes a package count of 30 tablets. The label also features barcodes, NDC number 62332-039-30, and contact info for medication guide access.*

FDA Label Image

Lamotrigine 200 mg

Lamotrigine Tablets USP 200 mg oral tablets label. Contains 30 tablets per container. Manufactured by Alembic Pharmaceuticals Limited, India, and Alembic Pharmaceuticals, Inc., USA. Includes storage instructions, dispensing guidance, NDC 62332-040-30, and a barcode. The label highlights '200 mg' strength prominently in orange.*

FDA Label Image

Lamotrigine 25 mg

Lamotrigine Tablets USP 25 mg oral tablets label by Alembic Pharmaceuticals Inc., showing 30 tablets per package. The label includes storage instructions (20° to 25°C, with permitted excursions), lot number, expiration date, barcode, NDC 62332-037-30, and directions to dispense the medication guide to patients.*

FDA Label Image

Description (Lamotrigine Descri)

This image shows a chart describing four variations of Lamotrigine tablets by Alembic Pharmaceuticals Inc. It details four strengths: 25 mg capsule-shaped tablets with 'L121' debossing, and round tablets with debossing codes 'L122' for 100 mg, 'L123' for 150 mg, and 'L124' for 200 mg. All tablets are white to off-white in color.*

FDA Label Image

Figure 1 (Lamotrigine Figure1)

A Kaplan-Meier failure probability curve chart comparing placebo and Lamotrigine tablets over weeks. The vertical axis shows failure probability (%) from 0 to 100, and the horizontal axis shows the duration in weeks, up to 100 weeks. The chart includes censored data points marked with plus signs for both placebo and Lamotrigine groups.*

FDA Label Image

Figure 2 (Lamotrigine Figure2)

A Kaplan-Meier failure probability curve comparing Lamotrigine tablets and placebo over weeks. The Y-axis shows failure probability percentage from 0 to 100%, and the X-axis shows time in weeks from 0 to 80. Two distinct survival curves are labeled for placebo and Lamotrigine tablets, with censored data points marked.*

FDA Label Image

Structure (Lamotrigine Str)

Chemical structure diagram of the active ingredient Lamotrigine, depicting its molecular formula with chlorine and nitrogen atoms arranged in a triazine ring and phenyl substituents.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.